BOE Technology Group Co., Ltd.: Clinical Trials

5 trials sponsored by BOE Technology Group Co., Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Not yet recruiting 3
Not applicable1Recruiting 1
Phase 21Not yet recruiting 1

Follow BOE Technology Group Co., Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NK Cell Injection for Advanced Solid Tumors
NK CELLS - Advanced Solid Tumors
Phase 1Not yet recruitingBOE Technology Group Co., Ltd.92026-09-012026-08-25
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors
NK Cells, NK cells + PD-(L)1 inhibitor + pemetrexed as first-line maintenance therapy, NK cells + cetuximab/bevacizumab + capecitabine as first-line maintenance therapy - NSCLC (Advanced Non-small Cell Lung Cancer), Colorectal Cancer
Phase 1 / Phase 2Not yet recruitingBOE Technology Group Co., Ltd.422026-08-012026-08-26
A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke
Placebo of Human Umbilical Cord Mesenchymal Stromal Cells Injection, Human Umbilical Cord Mesenchymal Stem Cells Injection - Acute Ischemic Stroke, AIS
Phase 1Not yet recruitingBOE Technology Group Co., Ltd.352026-06-302026-06-05
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
Cerebrovascular Disease Secondary Prevention Smart Management System - Ischemic Stroke, Transient Ischemic Attack (TIA)
Not applicableRecruitingBeijing Tiantan Hospital44902025-03-032026-01-21
Screening and Early Warning of Chronic Obstructive Pulmonary Disease Combined With Sleep Respiratory Disease Based on Medical Internet of Things
wearable devices - COPD, Osa Syndrome
UnknownPeking University Third Hospital6802020-01-012021-04-06

Conditions studied

Ischemic Stroke (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carnevale syndrome (1)  ·  Colorectal Neoplasms (1)  ·  Ischemic Attack, Transient (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Interventions

Bevacizumab (1)  ·  Capecitabine (1)  ·  Cetuximab (1)  ·  Pemetrexed (1)  ·  S 1 (combination) (1)  ·  Wearable Electronic Devices (1)

Countries

China (3)

Results publications

PMID 30615498, PMID 31167621, PMID 31708447, PMID 32160205, PMID 32475159, PMID 33323210, PMID 35533220, PMID 35703097, PMID 36221935, PMID 37459876, PMID 37800373, PMID 38418236, PMID 39043397